Mendelsohn AR, Larrick JW.2013.

Dietary modification of the microbiome affects risk for

cardiovascular disease. Rejuvenation Res. 2013 Jun;16(3):241-4.

Wang Z, et al.2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular

disease. Nature.2011;472(7341):57–63.

Higgins JP,Ortiz BL.2014. Energy Drink Ingredients and their Effect on Endothelial Function: A Review.
Beverages 2015, 1, 104-126; doi:10.3390/beverages1020104.

Ling B,Aziz C,Alcorn J.2012.Systematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during
Postnatal Development in Rat.Nutrition & Metabolism 2012, 9:66h.

Flanagan JL, Simmons PA, Vehige J, Willcox MDP, Garrett Q.2010.Role of carnitine in disease.
Nutrition & Metabolism 2010, 7:30.

Zhang W,Iso H,et al.2012. Associations of dietary magnesium intake with mortality from
cardiovascular disease: the JACC study. Atherosclerosis. 2012 Apr;221(2):587-95.

Miguel-Carrasco JL, Mate A, Monserrat MT, et al.2008. The role of inflammatory markers in the
cardioprotective effect of L-carnitine in L-NAME-induced hypertension. Am J
Hypertens. 2008;21(11):1231–1237.

Palmieri F.2008. Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys
Acta.2008;1777:564–578.

Fukami K, Yamagishi S, Sakai K,et al.2015. Oral L-carnitine supplementation increases

trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients. J Cardiovasc
Pharmacol.2015 Mar;65(3):289-95